Silence Therapeutics

NASDAQ: SLN · Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Aug 15, 2025, 3:59 PM
5.49
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT

Silence Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-45.31M -50.31M -47.37M -45.86M
Depreciation & Amortization
336K 498K 482K 427K
Stock-Based Compensation
16.31M 13.05M 10.25M 8.63M
Other Working Capital
-32.12M -11.98M -7.68M 11.36M
Other Non-Cash Items
-7.05M 9.07M -559K 347K
Deferred Income Tax
n/a n/a n/a 4.41M
Change in Working Capital
-33.02M -11.66M -8.26M 38.84M
Operating Cash Flow
-67.64M -39.35M -45.46M 6.81M
Capital Expenditures
-211K -45K -440K -1.33M
Cash Acquisitions
n/a n/a n/a -10M
Purchase of Investments
-139.17M -20.67M -16.13M 10M
Sales Maturities Of Investments
n/a 36.18M n/a 10M
Other Investing Acitivies
117.41M 958K 23K 10K
Investing Cash Flow
-21.97M 16.43M -16.54M 8.68M
Debt Repayment
n/a -174K -190K -211K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
142.09M n/a 43.24M 30.92M
Financial Cash Flow
142.09M 25.16M 43.05M 30.71M
Net Cash Flow
52.54M -785K -18.72M 46.09M
Free Cash Flow
-67.85M -39.4M -45.9M 5.47M